BRAVA: Building Resilience and Attachment in Vulnerable Adolescents
- Conditions
- Suicidal IdeationSuicide and Self-harm
- Interventions
- Other: Group InterventionBehavioral: Enhanced Treatment as Usual
- Registration Number
- NCT04751968
- Lead Sponsor
- Children's Hospital of Eastern Ontario
- Brief Summary
The prevalence of suicidal ideation (SI) among adolescents in North America is high, making it critical to develop evidence-based brief interventions for adolescents with SI that target healthy coping skills and relationships. BRAVA is a novel brief group intervention for adolescents with mild to moderate SI and their caregivers; youth are taught skills for coping and relating more effectively with others. Caregivers learn about adolescent development, effective parenting and the importance of connection. The goal of the randomized controlled trial is to assess the efficacy of a virtually-delivered, brief group intervention for adolescents with mild to moderate SI and their caregivers in reducing SI.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 99
- Adolescents 13 years old to 17.5 years old
- Mild to moderate suicidal ideation (SI without plan or gesture; 1 on the HEADS-ED) (Cappelli, et al., 2012)
- Interested in study participation
- Access to an electronic device with internet and email capabilities, and a functioning camera and microphone
- SI with plan or gesture (2 on HEADS ED; indicated plan or gesture)
- Comorbid disorders (psychosis, schizophrenia, developmental disabilities, major substance abuse, and severe eating disorders).
- Referring clinician has identified an externalizing disorder as a primary diagnosis or primary concern (e.g. Conduct Disorder)
- Currently participating in regular psychotherapy at least one time per week
- Currently under Children's Aid Society care
- Currently in the CHEO ED on a Form 1 or Form 2, or placed on a Section 17.
- Express difficulty with reading and writing
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group Intervention Group Intervention The intervention will consist of 6 psycho-educational group sessions for caregivers and 6 psycho-educational group sessions for adolescents. Adolescent and caregiver sessions will be held separately and will focus on different issues. Adolescents are taught skills for coping and relating more effectively with others. Caregivers learn about adolescent development, effective parenting and the importance of connection. The groups consist of 6 stand-alone modules permitting rolling entry and prompt access. Youth and Caregivers will receive a weekly text message reminder of their exit assessment date/time, homework from that week's intervention group and crisis resources. Enhanced Treatment as Usual Enhanced Treatment as Usual Youth and Caregivers will receive a weekly text message reminder of their exit assessment date/time, a mental health tip and crisis resources.
- Primary Outcome Measures
Name Time Method Suicidal Ideation 6 weeks Suicidal ideation will be measured using the Suicidal Ideation Questionnaire Junior (Reynolds, 1988). A decreased score in suicidal ideation over 6-weeks will indicate a positive outcome.
- Secondary Outcome Measures
Name Time Method Depression and Anxiety 6 weeks We will be assessing youth depression and anxiety with the youth version of the Revised Child Anxiety and Depression Scale (Chorpita et al., 2000). A decreased score in depression and anxiety over 6-weeks will indicate a positive outcome.
Attachment 6 weeks We will be assessing caregiver attachment with the adolescent version of the Adolescent Attachment Anxiety \& Avoidance Inventory (Morretti \& Obsuth, 2009). A decreased score in attachment between the adolescent and caregiver over 6-weeks will indicate a positive outcome.
Family Functioning 6 weeks Family functioning using the Family Assessment Device (Epstein, Baldwin, \& Bishop, 1983). A decreased score in family functioning over 6-weeks will indicate a positive outcome.
Trial Locations
- Locations (1)
CHEO
🇨🇦Ottawa, Ontario, Canada